|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/113 | |
| C12N 15/10 | |||
| A61K 31/712 |
| (11) | Patento numeris | 3507366 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17771348.4 |
| Europos patento paraiškos padavimo data | 2017-08-31 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-07-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-10-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2017/071912 |
| Data | 2017-08-31 |
| (87) | Numeris | WO 2018/041973 |
| Data | 2018-03-08 |
| (30) | Numeris | Data | Šalis |
| 201614858 | 2016-09-01 | GB | |
| 201616374 | 2016-09-27 | GB | |
| 201621467 | 2016-12-16 | GB | |
| 201703034 | 2017-02-24 | GB | |
| 201707508 | 2017-05-10 | GB |
| (72) |
TURUNEN, Janne Juha, NL
AALTO, Antti, NL
KLEIN, Bart, NL
VAN SINT FIET, Lenka, NL
BOUDET, Julien Auguste Germain, NL
|
| (73) |
ProQR Therapeutics II B.V.,
Zernikedreef 9, 2333 CK Leiden,
NL
|
| (54) | CHEMICALLY MODIFIED SINGLE-STRANDED RNA-EDITING OLIGONUCLEOTIDES |
| CHEMICALLY MODIFIED SINGLE-STRANDED RNA-EDITING OLIGONUCLEOTIDES |